Jalen Hurts has blood clots in his lungs, Eagles say in updated diagnosis

Jalen Hurts has been diagnosed with deep vein thrombosis and blood clots in both lungs, the Philadelphia Eagles and his agent, Nicole Lynn, said Monday. The updated diagnosis is a significant development beyond the superficial calf-clot description released earlier.

The joint statement says the quarterback is clinically stable, is being treated with anticoagulant medication and cannot take part in contact activities during that treatment. The team and Lynn say they expect him to recover fully.

What changed in Monday's announcement

In their 10:15 a.m. update, the team and Lynn say specialists in London initially diagnosed a superficial clot in Hurts' left calf. Further testing and monitoring produced the current diagnosis involving a deep vein and the lungs.

“Jalen's prognosis is very good, and we expect a full recovery,” the statement says. It adds that they anticipate an opportunity to resume contact football after he is off blood thinners and expect no long-term effects. Those are the expectations of the team and his agent, not a guarantee from NewsCubby or an independently established outcome.

The announcement does not establish what caused the clots. It should not be used to assign responsibility to a flight, a particular injury or another unconfirmed factor.

What the medical terms mean

The Centers for Disease Control and Prevention explains that deep vein thrombosis, or DVT, occurs when a clot forms in a deep vein, commonly in a leg. A pulmonary embolism occurs when part of a clot travels to the lungs. Both are serious medical conditions.

CDC guidance says anticoagulants help prevent further clot formation. Its treatment explanation notes that these medications reduce the blood's ability to clot; despite their everyday name, they do not literally thin it.

That background helps explain the vocabulary in the announcement. It cannot establish Hurts' individual recovery schedule, which depends on the clinicians treating him. Anyone with symptoms such as difficulty breathing, chest pain or coughing up blood should seek immediate medical attention, CDC advises.

What this means for the Eagles

NFL Network's report, published by Kevin Patra and updated Monday, cites Ian Rapoport and ESPN's Adam Schefter in reporting an expected absence for the remainder of the 2026 season. They reported a recovery period of about three months, placing a return this season in doubt.

That reported expectation and the official statement answer different questions: one describes the likely football timetable, while the other makes playing again conditional on the end of anticoagulant treatment without naming a date.

Hurts had already been placed on injured reserve. NewsCubby's October 18 coverage of the roster move and Tanner McKee's role remains available; Monday's story updates the diagnosis rather than presenting that earlier roster decision as new.

For now, the confirmed restriction is no contact activity during treatment. Any future clearance should come from a new official update, not from assumptions about the minimum injured-reserve period or speculation about a recovery deadline.

Photograph and reuse notes

Jalen Hurts at Lincoln Financial Field on November 14, 2022. Archive photograph, not an image from his medical treatment. Photo: All-Pro Reels / Joe Glorioso, CC BY-SA 2.0, via Wikimedia Commons. The website photograph is resized/compressed with responsive display cropping. Social adaptations add a crop, contrast gradient, NewsCubby branding and translated headline. The photograph and adapted cards retain CC BY-SA 2.0; no additional restrictions are imposed. Original photograph and rights record; license.